WeChat Mini Program
Old Version Features

Dummy Run for Planning of Isotoxic Dose-Escalated Radiation Therapy for Glioblastoma Used in the Pride Trial (Noa-28; Aro-2024-01; Ag-Nro-06)

Sebastian H. Maier,Stephan Schoenecker,Vasiliki Anagnostatou,Sylvia Garny,Alexander Nitschmann,Daniel F. Fleischmann,Marcel Buettner,David Kaul,Detlef Imhoff,Emmanouil Fokas,Clemens Seidel,Peter Hau,Oliver Koelbl,Ilinca Popp,Anca-Ligia Grosu,Jan Haussmann,Wilfried Budach,Eren Celik,Klaus-Henning Kahl,Elgin Hoffmann,Ghazaleh Tabatabai,Frank Paulsen,Adrien Holzgreve,Nathalie L. Albert,Ulrich Mansmann,Stefanie Corradini,Claus Belka,Maximilian Niyazi,Raphael Bodensohn

Clinical and Translational Radiation Oncology（2024）

Cited 0|Views23
Key words
Glioblastoma,Dose Escalation,PRIDE Trial,Bevacizumab,FET PET,QA
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined